A detailed history of Qube Research & Technologies LTD transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 181,994 shares of ELAN stock, worth $2.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,994
Previous 370,263 50.85%
Holding current value
$2.74 Million
Previous $6.03 Million 56.43%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.93 - $18.45 $2.43 Million - $3.47 Million
-188,269 Reduced 50.85%
181,994 $2.63 Million
Q1 2024

May 14, 2024

BUY
$14.37 - $16.46 $3.45 Million - $3.95 Million
239,758 Added 183.72%
370,263 $6.03 Million
Q4 2023

Feb 13, 2024

BUY
$8.6 - $14.94 $1.11 Million - $1.92 Million
128,805 Added 7576.76%
130,505 $1.94 Million
Q3 2023

Nov 13, 2023

SELL
$9.81 - $12.62 $4.13 Million - $5.32 Million
-421,346 Reduced 99.6%
1,700 $19,000
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $664,418 - $852,725
-82,230 Reduced 16.27%
423,046 $4.26 Million
Q1 2023

May 15, 2023

SELL
$8.79 - $14.58 $11.8 Million - $19.6 Million
-1,345,146 Reduced 72.69%
505,276 $4.75 Million
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $11.7 Million - $13.9 Million
1,016,981 Added 122.02%
1,850,422 $22.6 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $317,174 - $828,590
25,558 Added 3.16%
833,441 $10.3 Million
Q2 2022

Aug 15, 2022

BUY
$19.63 - $26.62 $4.67 Million - $6.33 Million
237,902 Added 41.74%
807,883 $15.9 Million
Q1 2022

May 09, 2022

SELL
$24.65 - $29.0 $1.85 Million - $2.18 Million
-75,188 Reduced 11.65%
569,981 $14.9 Million
Q4 2021

Feb 01, 2022

BUY
$27.74 - $34.09 $17.9 Million - $22 Million
645,169 New
645,169 $18.3 Million
Q3 2021

Nov 12, 2021

SELL
$29.2 - $36.72 $1.67 Million - $2.1 Million
-57,265 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$28.76 - $35.98 $1.65 Million - $2.06 Million
57,265 New
57,265 $1.99 Million
Q1 2021

May 14, 2021

SELL
$27.85 - $34.49 $1.71 Million - $2.11 Million
-61,307 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$27.53 - $33.79 $1.69 Million - $2.07 Million
61,307 New
61,307 $1.88 Million
Q3 2020

Nov 12, 2020

SELL
$21.1 - $29.13 $229,779 - $317,225
-10,890 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$18.94 - $24.93 $17,462 - $22,985
922 Added 9.25%
10,890 $234,000
Q1 2020

May 15, 2020

SELL
$16.68 - $32.25 $18,097 - $34,991
-1,085 Reduced 9.82%
9,968 $223,000
Q4 2019

Feb 13, 2020

BUY
$25.29 - $29.45 $279,530 - $325,510
11,053 New
11,053 $326,000
Q2 2019

Aug 02, 2019

SELL
$31.11 - $34.79 $767,017 - $857,747
-24,655 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $714,995 - $809,423
24,655 New
24,655 $791,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $7.14B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.